SIRT5 and central nervous system cancer: Additionally, we found that SIRT5 expression was significantly downregulated in the more aggressive classic (CL) and mesenchymal (ME) molecular subtypes of glioma compared to the proneural (PN) and neural (NE) subtypes [17] (Figure 1B), suggesting a correlation between low SIRT5 expression levels and aggressive tumor characteristics.